Your search :

212 results

Pierre Fabre Laboratories presents the first global study on the “epidemiology of acne”
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
Pierre Fabre Laboratories, committed to combating rare pediatric diseases via innovative therapies.
Pierre Fabre Laboratories and the EspeRare Foundation to be honored with the EURORDIS Company Award for Patient Engagement 2024, in their approach to co-developing a treatment for XLHED.
Eau Thermale Avène hits a billion euros in turnover, and strengthens its medical positioning.
Hervé Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories
Pierre Fabre confirmed as one of the world’s best employers
Pierre Fabre laboratories acquires a stake in MiYé
2023 Annual Report: Taking care of you helps us advance
The Green Impact index consortium is pleased to announce the publication of Afnor spec 2215 by Afnor: